Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 27. oktober 2023 kl. 16:15 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Martin Nicklasson | – | Kjøp | 20 000 | 16,36 NOK | 27. oktober 2023 | NO0010714785 | XOSL - Oslo Stock Exchange |
Vedlegg
- Attachment 231027.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, October 27, 2023 - Primary insider Martin Nicklasson, Chair of the Board of Nykode Therapeutics ASA, has today acquired 20,000 shares in Nykode Therapeutics AS at a price of NOK 16.36 per share. Following the transaction, Martin Nicklasson holds 52,000 shares in Nykode Therapeutics ASA.
Please see further details in the attached document.